Accent Microcell Ltd
Accent Microcell Q1 FY26 earnings call: Revenue & Margins
Q1 FY26 earnings call: what management guided on revenue, margins and order book.
The short version
Global MCC demand is approximately 250,000 metric tons annually; Indian demand is about 50,000 metric tons. The company expects a 15-20% CAGR growth over the next 3 to 5 years, with potentially higher growth in the near term.
From Accent Microcell Ltd's Q1 FY26 earnings-call transcript · updated 23 Aug 2026.
Revenue & Sales Performance
- Global MCC demand is approximately 250,000 metric tons annually; Indian demand is about 50,000 metric tons.
- Indian demand is growing at roughly 5-7% per year, with global growth rates around 7-7.5%.
- New capacities totaling 30,000-40,000 metric tons likely to come online in India over the next two years.
- Company expects 15-20% CAGR growth over 3-5 years, with possible higher near-term growth due to ramp-up of new plants.
- New plants expected to achieve about 60% utilization in the first year.
- Peak revenue potential estimated around INR 700 crore from all three units running fully, with top-line from the new plant around INR 150 crore at peak.
2 more points from Accent Microcell Ltd's call on revenue
Pro opens every point from 15K+ earnings calls
Profitability & Margins
See what Accent Microcell Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Total capex for Unit 3 (Phase 1 and Phase 2, excluding land) is around ₹105-110 crore.
- Phase 1 includes a new plant with ₹110 crore approx. capex.
- Phase 2 of Unit 3 involves a 12,000 metric tons MCC plant with a capex of ₹55-60 crore (excluding land).
- The company has funded the capex largely through rights issue, minimizing significant debt.
- Nominal debt may be considered for working capital requirements.
- Land purchase (~₹6 crore) was made adjacent to the Pirana plant for warehouse/inventory storage.
2 more points from Accent Microcell Ltd's call on capex
Pro opens every point from 15K+ earnings calls
Top-ranked in Pharmaceuticals & Biotechnology
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Accent Microcell Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
- The company already has 5 to 6 months of orders in hand for the new products.
- They expect to achieve around 60% capacity utilization within the first 3 to 4 months of operation.
- For phase one and phase two expansions, orders and business are secured, with no threat perceived to the order book.
- The company has good visibility and confirmed orders aiding in ramp-up plans post expansions.
Continue your research
What Accent Microcell Ltd's management said in earlier quarters
Others in Pharmaceuticals & Biotechnology this season
- NGL Fine Chem Ltd (Q1 FY26)
Q1FY26 Revenue from operations: ₹104.19 crores . Key concall takeaways from NGL Fine Chem Ltd's Q1 FY26 earnings call — and how it ranks against sector peers.
- Fermenta Biotech Ltd (Q1 FY26)
Q1FY26 Revenue from operations: INR 136 crore, up 79% YoY (Page 8) . Key concall takeaways from Fermenta Biotech Ltd's Q1 FY26 earnings call — and how it ranks…
- Amrutanjan Health Care Ltd (Q1 FY26)
94.05 Cr, up 12.31% from Rs. Key concall takeaways from Amrutanjan Health Care Ltd's Q1 FY26 earnings call — and how it ranks against sector peers.
- Sigachi Industries Ltd (Q1 FY26)
INR 60 crores from Hyderabad plant in next 6 months, with some recovery from other units (Dahej, Jhagadia). Key concall takeaways from Sigachi Industries Ltd's…
Arthneeti Pro · Annual
Accent Microcell Ltd and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Accent Microcell Ltd Q1 FY26 results?
Global MCC demand is approximately 250,000 metric tons annually; Indian demand is about 50,000 metric tons. The company expects a 15-20% CAGR growth over the next 3 to 5 years, with potentially higher growth in the near term.
What is Accent Microcell Ltd share price analysis?
Accent Microcell Ltd currently shows a neutral. The stock trades at a P/E of 31.9 with a market cap of ₹1,399 Cr. Investors should review the full earnings analysis for detailed insights.
Is Accent Microcell Ltd planning capital expenditure?
Total capex for Unit 3 (Phase 1 and Phase 2, excluding land) is around ₹105-110 crore. - Phase 1 includes a new plant with ₹110 crore approx.
Keep Accent Microcell Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.